Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.
Technology solutions from early phase through to post-marketing.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
Developing transformative therapies requires a flexible approach.
Partners making a difference.
An early pioneer in oncology CGT, ICON has contributed to over 60 FDA/EMA approved therapies in the last 5 years.
ICON's therapeutic experts contribute regularly to industry publications on the latest medical, scientific and clinical developments.
Adapting to the needs of chronic disease patient populations
Regulatory readiness for next-generation AI-enabled software as a medical device (SaMD)
Plotting a course to bring APAC-developed drugs to the world
ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
8 November 2026. Register now.
5 November 2026. Register now.
ICON Cares is our commitment to making a positive impact on our people, environment and our community.
Delivering successful outcomes across the clinical development lifecycle.